Tanya Stoyanova

4.3k total citations · 3 hit papers
57 papers, 2.6k citations indexed

About

Tanya Stoyanova is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Tanya Stoyanova has authored 57 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 22 papers in Molecular Biology and 21 papers in Oncology. Recurrent topics in Tanya Stoyanova's work include Prostate Cancer Treatment and Research (25 papers), Cancer-related Molecular Pathways (7 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Tanya Stoyanova is often cited by papers focused on Prostate Cancer Treatment and Research (25 papers), Cancer-related Molecular Pathways (7 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Tanya Stoyanova collaborates with scholars based in United States, China and Portugal. Tanya Stoyanova's co-authors include Meghan A. Rice, Jiaoti Huang, Sanjay V. Malhotra, Owen N. Witte, En‐Chi Hsu, Andrew S. Goldstein, Justin M. Drake, Dragana Kopanja, Pradip Raychaudhuri and Merve Aslan and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Advanced Materials.

In The Last Decade

Tanya Stoyanova

55 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells

2016 280 citations John K. Lee, Tanya Stoyanova et al. profile →
Second-Generation Antiandrogens: From Discovery to Standard of Care in Castration Resistant Prostate Cancer

2019 221 citations Meghan A. Rice, Sanjay V. Malhotra et al. profile →
Ferroptosis Inducers Are a Novel Therapeutic Approach for Advanced Prostate Cancer

2021 215 citations Ali Ghoochani, En‐Chi Hsu et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tanya Stoyanova United States	28	1.3k	1.1k	716	628	239	57	2.6k
Debabrata Saha United States	29	1.1k 0.9×	576 0.5×	676 0.9×	471 0.8×	284 1.2×	111	2.4k
Michael H. Muders Germany	30	1.3k 1.0×	554 0.5×	904 1.3×	502 0.8×	395 1.7×	79	2.7k
Ruoxiang Wang United States	35	1.6k 1.3×	904 0.8×	1.1k 1.6×	777 1.2×	482 2.0×	86	3.2k
Baijun Dong China	30	1.3k 1.0×	726 0.6×	378 0.5×	645 1.0×	263 1.1×	90	2.2k
Yuri Sheinin United States	29	1.2k 0.9×	867 0.8×	1.1k 1.5×	453 0.7×	417 1.7×	60	2.9k
Susanne Fuessel Germany	29	1.4k 1.1×	611 0.5×	559 0.8×	644 1.0×	183 0.8×	91	2.5k
B. Smith United States	24	897 0.7×	698 0.6×	587 0.8×	304 0.5×	447 1.9×	84	2.2k
Jaclyn Y. Hung United States	24	1.4k 1.1×	1.3k 1.1×	1.2k 1.7×	770 1.2×	491 2.1×	35	3.2k
Ling Geng United States	28	1.9k 1.5×	539 0.5×	981 1.4×	866 1.4×	227 0.9×	50	3.1k
Rainer Kehlbach Germany	25	1.1k 0.9×	507 0.4×	815 1.1×	367 0.6×	238 1.0×	57	2.4k

Countries citing papers authored by Tanya Stoyanova

Since Specialization

Citations

This map shows the geographic impact of Tanya Stoyanova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tanya Stoyanova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tanya Stoyanova more than expected).

Fields of papers citing papers by Tanya Stoyanova

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tanya Stoyanova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tanya Stoyanova. The network helps show where Tanya Stoyanova may publish in the future.

Co-authorship network of co-authors of Tanya Stoyanova

This figure shows the co-authorship network connecting the top 25 collaborators of Tanya Stoyanova. A scholar is included among the top collaborators of Tanya Stoyanova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tanya Stoyanova. Tanya Stoyanova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sinawang, Prima Dewi, Mehmet Ozgün Ozen, Shiqin Liu, et al.. (2025). Extracellular Vesicles in Serum Carry Trop2 Protein as a Potential Molecular Indicator in Prostate Cancer. Journal of Extracellular Biology. 4(9). e70083–e70083. 1 indexed citations

Liu, Shiqin, En‐Chi Hsu, Merve Aslan, et al.. (2025). Extracellular Domain Shedding of TROP2 Activates EGFR Signaling to Drive Prostate Cancer Metastasis. Cancer Research. 85(23). 4632–4647.

Liu, Shiqin, et al.. (2024). Protocol for establishing spontaneous metastasis in mice using a subcutaneous tumor model. STAR Protocols. 5(3). 103239–103239. 2 indexed citations

Shen, Michelle, Fernando Jose Garcia-Marques, Shiqin Liu, et al.. (2024). Identification of a 5-gene signature panel for the prediction of prostate cancer progression. British Journal of Cancer. 131(11). 1748–1761. 1 indexed citations

Guimarães, Carlos F., Shiqin Liu, Jie Wang, et al.. (2024). Co-axial hydrogel spinning for facile biofabrication of prostate cancer-like 3D models. Biofabrication. 16(2). 25017–25017. 4 indexed citations

Bangayan, Nathanael J., Liang Wang, Donghui Cheng, et al.. (2023). Dual-inhibitory domain iCARs improve the efficiency of the AND-NOT gate CAR T strategy. Proceedings of the National Academy of Sciences. 120(47). e2312374120–e2312374120. 29 indexed citations

Wang, Jie, Fernando Soto, Peng Ma, et al.. (2022). Acoustic Fabrication of Living Cardiomyocyte-based Hybrid Biorobots. ACS Nano. 16(7). 10219–10230. 27 indexed citations

Garcia-Marques, Fernando Jose, Shiqin Liu, Sarah M. Totten, et al.. (2022). Protein signatures to distinguish aggressive from indolent prostate cancer. The Prostate. 82(5). 605–616. 10 indexed citations

Liu, Shiqin, En‐Chi Hsu, Michelle Shen, Merve Aslan, & Tanya Stoyanova. (2022). Metastasis Model to Test the Role of Notch Signaling in Prostate Cancer. Methods in molecular biology. 2472. 221–233. 2 indexed citations

10.

Ghoochani, Ali, En‐Chi Hsu, Merve Aslan, et al.. (2021). Ferroptosis Inducers Are a Novel Therapeutic Approach for Advanced Prostate Cancer. Cancer Research. 81(6). 1583–1594. 215 indexed citations breakdown →

11.

Xie, Jinghang, Meghan A. Rice, Zixin Chen, et al.. (2021). In Vivo Imaging of Methionine Aminopeptidase II for Prostate Cancer Risk Stratification. Cancer Research. 81(9). 2510–2521. 11 indexed citations

12.

Chen, Yun‐Sheng, Yang Zhao, Corinne Beinat, et al.. (2021). Ultra-high-frequency radio-frequency acoustic molecular imaging with saline nanodroplets in living subjects. Nature Nanotechnology. 16(6). 717–724. 26 indexed citations

13.

Aslan, Merve, En‐Chi Hsu, Fernando Jose Garcia-Marques, et al.. (2021). Oncogene-mediated metabolic gene signature predicts breast cancer outcome. npj Breast Cancer. 7(1). 141–141. 40 indexed citations

14.

Liu, Shiqin, Michelle Shen, En‐Chi Hsu, et al.. (2020). Discovery of PTN as a serum-based biomarker of pro-metastatic prostate cancer. British Journal of Cancer. 124(5). 896–900. 28 indexed citations

15.

Tailor, Dhanir, Catherine C. Going, Vineet Kumar, et al.. (2020). Novel Aza-podophyllotoxin derivative induces oxidative phosphorylation and cell death via AMPK activation in triple-negative breast cancer. British Journal of Cancer. 124(3). 604–615. 20 indexed citations

16.

Rice, Meghan A., et al.. (2019). Loss of Notch1 Activity Inhibits Prostate Cancer Growth and Metastasis and Sensitizes Prostate Cancer Cells to Antiandrogen Therapies. Molecular Cancer Therapeutics. 18(7). 1230–1242. 41 indexed citations

17.

Going, Catherine C., Dhanir Tailor, Vineet Kumar, et al.. (2018). Quantitative Proteomic Profiling Reveals Key Pathways in the Anticancer Action of Methoxychalcone Derivatives in Triple Negative Breast Cancer. Journal of Proteome Research. 17(10). 3574–3585. 19 indexed citations

18.

Jiao, Xuanmao, Adam Ertel, Mathew C. Casimiro, et al.. (2016). v-Src Oncogene Induces Trop2 Proteolytic Activation via Cyclin D1. Cancer Research. 76(22). 6723–6734. 21 indexed citations

19.

Drake, Justin M., Nicholas Graham, John K. Lee, et al.. (2013). Metastatic castration-resistant prostate cancer reveals intrapatient similarity and interpatient heterogeneity of therapeutic kinase targets. Proceedings of the National Academy of Sciences. 110(49). E4762–9. 90 indexed citations

20.

Cai, Houjian, Sanaz Memarzadeh, Tanya Stoyanova, et al.. (2012). Collaboration of Kras and Androgen Receptor Signaling Stimulates EZH2 Expression and Tumor-Propagating Cells in Prostate Cancer. Cancer Research. 72(18). 4672–4681. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact